Jafron Biomedical Co.,Ltd. (300529.SZ)
CNY 30.04
(-0.07%)
CNY 30.04
(-0.07%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 384.99 Million CNY | 10.27% |
| 2022 | 349.12 Million CNY | 77.63% |
| 2021 | 196.54 Million CNY | 62.88% |
| 2020 | 120.67 Million CNY | 30.72% |
| 2019 | 92.31 Million CNY | 50.94% |
| 2018 | 61.15 Million CNY | 35.19% |
| 2017 | 45.23 Million CNY | -10.39% |
| 2016 | 50.48 Million CNY | 29.41% |
| 2015 | 39.01 Million CNY | 11.23% |
| 2014 | 35.07 Million CNY | 28.61% |
| 2013 | 27.26 Million CNY | 12.85% |
| 2012 | 24.16 Million CNY | 31.94% |
| 2011 | 18.31 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 320.89 Million CNY | -16.65% |
| 2024 Q3 | 312.56 Million CNY | -2.35% |
| 2024 Q2 | 320.08 Million CNY | -0.25% |
| 2023 Q4 | 384.99 Million CNY | 9.29% |
| 2023 FY | 384.99 Million CNY | 10.27% |
| 2023 Q3 | 352.26 Million CNY | -2.86% |
| 2023 Q2 | 362.65 Million CNY | -2.21% |
| 2023 Q1 | 370.83 Million CNY | 6.22% |
| 2022 Q2 | 223.96 Million CNY | 7.27% |
| 2022 Q1 | 208.78 Million CNY | 6.23% |
| 2022 FY | 349.12 Million CNY | 77.63% |
| 2022 Q4 | 349.12 Million CNY | 11.33% |
| 2022 Q3 | 313.59 Million CNY | 40.02% |
| 2021 Q2 | 148.11 Million CNY | 17.13% |
| 2021 FY | 196.54 Million CNY | 62.88% |
| 2021 Q1 | 126.45 Million CNY | 4.79% |
| 2021 Q3 | 187.71 Million CNY | 26.74% |
| 2021 Q4 | 196.54 Million CNY | 4.7% |
| 2020 Q2 | 98.75 Million CNY | 7.72% |
| 2020 FY | 120.67 Million CNY | 30.72% |
| 2020 Q1 | 91.67 Million CNY | -0.69% |
| 2020 Q4 | 120.67 Million CNY | -0.48% |
| 2020 Q3 | 121.25 Million CNY | 22.79% |
| 2019 Q1 | 61.36 Million CNY | 0.34% |
| 2019 Q2 | 60.87 Million CNY | -0.79% |
| 2019 Q3 | 85.12 Million CNY | 39.82% |
| 2019 Q4 | 92.31 Million CNY | 8.45% |
| 2019 FY | 92.31 Million CNY | 50.94% |
| 2018 FY | 61.15 Million CNY | 35.19% |
| 2018 Q4 | 61.15 Million CNY | 3.2% |
| 2018 Q3 | 59.25 Million CNY | 23.03% |
| 2018 Q2 | 48.16 Million CNY | -3.24% |
| 2018 Q1 | 49.77 Million CNY | 10.04% |
| 2017 Q1 | 44.55 Million CNY | -11.75% |
| 2017 FY | 45.23 Million CNY | -10.39% |
| 2017 Q4 | 45.23 Million CNY | -3.36% |
| 2017 Q3 | 46.81 Million CNY | 6.38% |
| 2017 Q2 | 44 Million CNY | -1.22% |
| 2016 FY | 50.48 Million CNY | 29.41% |
| 2016 Q3 | 59.55 Million CNY | 15.9% |
| 2016 Q2 | 51.38 Million CNY | 21.48% |
| 2016 Q1 | 42.29 Million CNY | 8.42% |
| 2016 Q4 | 50.48 Million CNY | -15.23% |
| 2015 Q1 | - CNY | 0.0% |
| 2015 FY | 39.01 Million CNY | 11.23% |
| 2015 Q4 | 39.01 Million CNY | 0.0% |
| 2015 Q2 | 37.19 Million CNY | 0.0% |
| 2014 FY | 35.07 Million CNY | 28.61% |
| 2013 FY | 27.26 Million CNY | 12.85% |
| 2012 FY | 24.16 Million CNY | 31.94% |
| 2011 FY | 18.31 Million CNY | 0.0% |